Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Reviva Pharmaceuticals (RVPH) Q2 2026 Earnings
RVPH
13
May
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.89
-1.3
-0.71
-0.12
Details
Expected EPS
-0.355
Actual EPS
-0.46
Surprise EPS
-0.11
Surprise Percent
+29.58%
Description
Reviva Pharmaceuticals (RVPH) has reported earnings of -0.46 per share for Q2 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login